BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10929916)

  • 1. Short-Course antimicrobial therapy for upper respiratory tract infections.
    Guay DR
    Clin Ther; 2000 Jun; 22(6):673-84. PubMed ID: 10929916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-course antimicrobial therapy of respiratory tract infections.
    Guay D
    Drugs; 2003; 63(20):2169-84. PubMed ID: 14498754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB
    Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
    Cohen R
    Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients.
    Tran D; Muchant DG; Aronoff SC
    J Pediatr; 2001 Jul; 139(1):93-9. PubMed ID: 11445800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-duration therapy for respiratory tract infections.
    Goff DA
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics for upper respiratory tract infections: an overview of Cochrane reviews.
    Arroll B
    Respir Med; 2005 Mar; 99(3):255-61. PubMed ID: 15733498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS; Jones RN
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
    Block SL; Cifaldi M; Gu Y; Paris MM
    Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otitis media.
    Gupta BD; Singh A
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S24-31. PubMed ID: 11980456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antimicrobial agents for upper respiratory tract infections in Taiwanese children.
    Huang YH; Huang YC
    Chang Gung Med J; 2005 Nov; 28(11):758-64. PubMed ID: 16422181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
    Bowlware KL; McCracken GH; Lozano-Hernandez J; Ghaffar F
    Pediatr Infect Dis J; 2006 Mar; 25(3):208-10. PubMed ID: 16511381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose azithromycin for respiratory tract infections.
    Law C; Amsden GW
    Ann Pharmacother; 2004 Mar; 38(3):433-9. PubMed ID: 14970367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
    Bereznoy VV; Riley DS; Wassmer G; Heger M
    Altern Ther Health Med; 2003; 9(5):68-79. PubMed ID: 14526713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.